NCT02860624View on ClinicalTrials.gov

Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

550

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

April 30, 2013

Conditions
Gastroesophageal Reflux Disease
Interventions
DRUG

10 mg ilaprazole

Two 5-mg ilaprazole tablets (Livzon Pharm Group Inc., China) being taken orally each morning on an empty stomach for 8 weeks

DRUG

40mg esomeprazole

One 20-mg omeprazole capsule (AstraZeneca, Losec) being taken orally each morning on an empty stomach for 8 weeks

Sponsors
All Listed Sponsors
lead

Livzon Pharmaceutical Group Inc.

INDUSTRY